Ascot absence is just a blip in Princess of Wales's remarkable recovery
The official list of carriages in the Royal Procession had her name on it, along with those of the King, the Queen and the Prince of Wales, in what was expected to be her return to the summer season after her chemotherapy this time last year.
In the end, it was not to be. In the hours ahead of the procession, Kensington Palace confirmed that the Princess would be unable to attend.
It is said that while she was understandably disappointed not to attend, the Princess was mindful of treading a careful line as she returns to work.
It is a salient reminder that life, even for the royals, is not a fairytale. There is no magic wand for health.
There is no cause for alarm, we are told, backed by evidence of the Princess laughing and happy at the Garter Day ceremony at Windsor Castle just two days ago.
She has, in truth, been staging a remarkable comeback. Since the September video in which she announced that she had finished her chemotherapy, the Princess has surpassed all expectations in her steady march back to work.
From a lively anniversary trip to the Isle of Mull to placing a considered spotlight on Britain's creative sector at the V&A last week, she has looked happy, healthy and – as far as the public could see – as if she had never been away.
At Trooping the Colour on Saturday, she appeared flawless, standing beside the King in the public eye for hours and watching over her well-behaved children.
However, behind closed doors, it seems, things have not been so blissfully uncomplicated. The 'cancer journey', Catherine said in September, 'is complex, scary and unpredictable for everyone, especially those closest to you'.
'Much needed time to heal'
Almost exactly a year ago, as she attempted to reconcile her deeply private health issues with her public role, she said she was experiencing 'good days and bad days'.
'Taking each day as it comes, listening to my body, and allowing myself to take this much needed time to heal,' she said.
Since then, the Princess has made a valiant effort to get back into the public eye.
At a time when the public would have given her grace in recovery, she has signed up to public engagements (more than 20 this year), and high-profile Royal events at which every camera lens is focused on her face.
Her appearance, recently so healthy, has belied how difficult things were last year, and how hard the fight to return to normality has been.
The King and his daughter-in-law have walked similar paths this year in very different ways.
While the King, as a 76-year-old head of state, has largely ploughed on during cancer treatment, packing his diary with domestic engagements and international travel, the Princess – correctly – has had her mind on other things.
With three small children, a future King among them, she is focused on the long term, supporting her husband and being there in all senses for Prince George, Princess Charlotte and Prince Louis.
She is disappointed to miss Ascot. But the big picture, as she, William and their advisers know, is more important.
The watchword at the Palace is 'balance'. Her illness was serious, sources emphasise, and the long-term effects for any patient are unpredictable.
The public are kind enough, nowadays, to understand that royals are human and they cannot perform at all times.
The summer season at Ascot will survive, with royals aplenty. The presence of the Prince of Wales, who would have no qualms about shouldering criticism to skip the event to be by his wife's side if needed, as well as that of Carole Middleton, the Princess's mother, was reassuring.
The Princess is likely to be seen again very soon, at Wimbledon as well as official engagements, before the children break up for their school holidays.
'Although I have finished chemotherapy, my path to healing and full recovery is long and I must continue to take each day as it comes,' she said in September.
This year, she has made it look easy – but it is not.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
Are YOUR dizzy spells being caused by hidden nervous system problems that GPs often fail to spot... and could the cure be a 30p pill?
For more than 20 years, mother-of-two Kerry Clayton endured dizzy spells, fainting and constant light-headedness – only to have her concerns repeatedly dismissed by doctors. Her symptoms first appeared in her teens when she fainted during an exam. At the time, it was put down to stress. But the episodes kept happening – at work, in busy crowds – until they became, as she puts it, 'part of everyday life'.
Daily Mail
3 hours ago
- Daily Mail
Fat jabs like Ozempic and Mounjaro threaten to push up pension age as life expectancy rises
The spread of 'fat jabs' such as Ozempic could lead to a rise in the state pension age because previously obese workers will live longer than expected, Government advisers have warned. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted. Users of the drugs, which also include Mounjaro and Wegovy, typically lose about 15 per cent of their body weight, leading to knock-on health benefits such as lower cholesterol levels and reduced blood pressure. Health Secretary Wes Streeting aims to widen the availability of the drugs on the NHS to lessen the burden on the Health Service and boost employment, arguing that 'our widening waistbands' are 'holding back our economy'. Illness as a result of obesity causes people to take an extra four sick days a year on average. But a Government source told The Mail on Sunday: 'Obviously everyone can see the health benefits. But some people in the Treasury are worried about the impact on the pension crisis. Obesity is a big killer. 'And if people are starting to live a lot longer because they're not overweight that's quickly going to become an issue. Especially if we're going to see it regularly being prescribed on the NHS, as Wes is advocating.' The NHS currently offers the medicines for the management of obesity in certain patients. With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations about life expectancy – and therefore the bill faced by the Department for Work and Pensions – will have to be adjusted (file image) The state pension age will officially rise next year from 66 to 67, and then again to 68 between 2044 and 2046 – although growing pressure on public funds means an upcoming pension review by Work and Pensions Secretary Liz Kendall could hike that age further. Chancellor Rachel Reeves is facing a £50billion 'fiscal hole' in the public finances she will need to close in Autumn's Budget: measures considered include tighter inheritance tax rules and an increase in 'sin taxes' on tobacco and gambling. The triple lock protection for the state pension is also becoming a growing burden, with spiking inflation predicted to push the full amount to £12,451 next year – a £478 rise from its current level of £11,973. According to the forecasts, the state pension will cost the Exchequer £151.42 billion that year – £430 million higher than the £150.99 billion bill anticipated as a result of previous Bank Of England inflation forecasts. Mr Streeting hopes the weight-loss jabs will ease the burden on the NHS' budget, which will rise by 3.3 per cent next year to £192 billion.
Daily Mail
4 hours ago
- Daily Mail
Surge in cannabis-induced psychotic episodes across the UK as potency of strains has increased
Cannabis-induced psychosis is becoming increasingly common across the UK, a leading psychiatrist has warned. The widely used class B drug – also known as marijuana or weed – can cause dependency, and, in the year to March 2024, 2.3million people in the UK reported using it. But while regular use has more than halved in the past two decades, the number of cannabis-induced psychosis episodes has spiked as varieties on sale have become stronger. Those experiencing a psychotic episode commonly have symptoms such as hallucinations, dissociation or unusual changes in behaviour. And while these resolve in most cases, side-effects can last for years. Studies show cannabis can even trigger schizophrenia – a chronic mental health condition characterised by psychotic episodes where individuals lose touch with reality, experiencing delusions and hallucinations. Dr Niall Campbell, a consultant psychiatrist at the Priory rehabilitation centre, warns of a deepening public health issue, stemming from easy online access to highly potent forms of the drug known as 'skunk'. Made from unpollinated cannabis plants which naturally contain higher levels of THC – the main psychoactive ingredient – skunk greatly increases the risk of paranoia and hallucinations. 'There has been a visible rise in the number of people needing intensive support for psychosis as a result of cannabis use,' said Dr Campbell. 'I don't think this is surprising given how easy skunk is to buy. What begins with smoking a few 'joints' and feeling a bit paranoid can easily escalate. Over time people can reach a psychotic state which won't go away, even if they stop smoking – they can become very depressed or suicidal.' It comes after the London Drugs Commission released a report earlier this year calling for more services to tackle cannabis addiction.
